EP1877042A4 - Bioenhanced compositions - Google Patents
Bioenhanced compositionsInfo
- Publication number
- EP1877042A4 EP1877042A4 EP06750455A EP06750455A EP1877042A4 EP 1877042 A4 EP1877042 A4 EP 1877042A4 EP 06750455 A EP06750455 A EP 06750455A EP 06750455 A EP06750455 A EP 06750455A EP 1877042 A4 EP1877042 A4 EP 1877042A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- bioenhanced
- compositions
- bioenhanced compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN477MU2005 | 2005-04-18 | ||
IN315MU2006 | 2006-03-06 | ||
PCT/US2006/014422 WO2006113631A2 (en) | 2005-04-18 | 2006-04-18 | Bioenhanced compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1877042A2 EP1877042A2 (en) | 2008-01-16 |
EP1877042A4 true EP1877042A4 (en) | 2011-03-02 |
Family
ID=37115820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06750455A Withdrawn EP1877042A4 (en) | 2005-04-18 | 2006-04-18 | Bioenhanced compositions |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1877042A4 (en) |
JP (1) | JP2008536929A (en) |
KR (1) | KR20080042039A (en) |
AU (1) | AU2006236497A1 (en) |
CA (1) | CA2605183A1 (en) |
IL (1) | IL186721A0 (en) |
MX (1) | MX2007012947A (en) |
WO (1) | WO2006113631A2 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090123543A1 (en) * | 2006-01-02 | 2009-05-14 | Rubicon Research Private Limited | Pharmaceutical compositions |
CN101528224A (en) * | 2006-09-05 | 2009-09-09 | 阿斯利康(瑞典)有限公司 | Pharmaceutical composition comprising candesartan cilexetil |
KR101434334B1 (en) * | 2006-10-20 | 2014-08-28 | 아비에 비.브이. | Micellar nanoparticles of chemical substances |
US7923026B2 (en) | 2006-10-20 | 2011-04-12 | Solvay Pharmaceuticals B.V. | Embedded micellar nanoparticles |
WO2008064338A2 (en) * | 2006-11-22 | 2008-05-29 | Rubicon Research Pvt. Ltd. | Valsartan formulation for pulsatile delivery |
EP2099431B1 (en) * | 2006-11-28 | 2013-06-05 | Laboratorios Liconsa, S.A. | Stabilized solid pharmaceutical composition of candesartan cilexetil |
RU2009125613A (en) * | 2006-12-05 | 2011-01-20 | Новартис АГ (CH) | MICROEMULSION MEDICINAL FORMS OF VALSARTAN AND METHODS FOR PRODUCING THEM |
US20080152717A1 (en) * | 2006-12-14 | 2008-06-26 | Isp Investments, Inc. | Amorphous valsartan and the production thereof |
WO2008084504A2 (en) * | 2007-01-12 | 2008-07-17 | Rubicon Research Private Limited | Pharmaceutical compositions of angiotensin ii receptor blockers |
KR20090130325A (en) * | 2007-04-25 | 2009-12-22 | 테바 파마슈티컬 인더스트리즈 리미티드 | Pharmaceutical excipient complex |
US20100278909A1 (en) * | 2007-06-06 | 2010-11-04 | Dexcel Ltd. | Process for forming solid oral dosage forms of angiotensin ii receptor antagonists |
EP2182927A2 (en) * | 2007-08-01 | 2010-05-12 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical compositions of candesartan |
KR20100091963A (en) * | 2007-10-09 | 2010-08-19 | 노파르티스 아게 | Pharmaceutical formulation of valsartan |
PE20091041A1 (en) * | 2007-10-19 | 2009-08-22 | Abbott Gmbh & Co Kg | SOLID DISPERSION PRODUCT CONTAINING A COMPOUND BASED ON N-ARYL UREA |
JP5222550B2 (en) * | 2007-12-27 | 2013-06-26 | 財團法人工業技術研究院 | Sustained release composition and method for producing the same |
WO2009084040A1 (en) * | 2007-12-28 | 2009-07-09 | Rubicon Research Private Limited | Once a day formulation of angiotensin receptor blockers |
EP2257288A1 (en) * | 2008-02-28 | 2010-12-08 | Novartis AG | Valsartan solid oral dosage forms and methods of making such formulations |
JP2011522050A (en) * | 2008-06-03 | 2011-07-28 | ノバルティス アーゲー | Pulsed release of valsartan |
PT2165702E (en) | 2008-09-17 | 2012-02-07 | Helm Ag | Stable and readily dissolved compositions of candesartan cilexetil prepared with wet granulation |
DE102008047910A1 (en) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tabletting excipient based on lactose and cellulose |
WO2010151080A2 (en) * | 2009-06-25 | 2010-12-29 | 진양제약 주식회사 | Pharmaceutical composition containing carboxylosartan and a production method therefor |
WO2011028016A2 (en) * | 2009-09-04 | 2011-03-10 | 한올바이오파마주식회사 | Pharmaceutical preparation comprising beta-adrenergic blockers and angiotensin ii receptor blockers |
US9358204B2 (en) * | 2012-02-08 | 2016-06-07 | Supernus Pharmaceuticals, Inc. | Formulations of viloxazine |
WO2014088123A1 (en) * | 2012-12-05 | 2014-06-12 | Sawai Pharmaceutical Co., Ltd. | Candesartan cilexetil-containing preparation |
JP6379043B2 (en) | 2013-01-30 | 2018-08-22 | 沢井製薬株式会社 | Pharmaceutical composition containing candesartan cilexetil |
WO2016005994A2 (en) * | 2014-07-06 | 2016-01-14 | Gattefosse India Pvt. Ltd. | Pharmaceutical composition comprising solid dispersion of bcs class ii drugs with gelucires |
US9687475B1 (en) | 2016-03-24 | 2017-06-27 | Ezra Pharma Llc | Extended release pharmaceutical formulations with controlled impurity levels |
US9675585B1 (en) | 2016-03-24 | 2017-06-13 | Ezra Pharma | Extended release pharmaceutical formulations |
IL273658B2 (en) | 2017-10-04 | 2024-10-01 | Celgene Corp | Compositions and methods of use of cis-4-[2-{[(3s,4r)-3-fluorooxan-4-yl] amino}-8-(2,4,6-trichloroanilino)-9h-purin-9-yl]-1-methylcyclohexane-1-carboxamide |
CN109350609A (en) * | 2018-11-14 | 2019-02-19 | 常州大学 | A kind of preparation of chitosan package zeins nanoparticle and the application for loading acacetin sodium salt |
CN113933472B (en) * | 2020-06-29 | 2024-07-09 | 武汉武药科技有限公司 | Dissolution medium for determining dissolution rate of telmisartan solid preparation and application thereof |
CN112516105A (en) * | 2020-12-10 | 2021-03-19 | 成都恒瑞制药有限公司 | Losartan potassium oral preparation and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030152622A1 (en) * | 2001-10-25 | 2003-08-14 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral diuretic |
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
WO2004105694A2 (en) * | 2003-05-22 | 2004-12-09 | Lipocine, Inc. | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
WO2005041929A1 (en) * | 2003-11-03 | 2005-05-12 | Lipocine, Inc | Pharmaceutical compositions with synchronized solubilizer release |
WO2005056607A1 (en) * | 2003-12-12 | 2005-06-23 | Belupo-Lijekovi I Kozmetika D.D. | PROCESS FOR PRODUCTION OF INCLUSION COMPLEXES OF VALSARTAN WITH β-CYCLODEXTRIN |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
JP3751287B2 (en) * | 2002-03-27 | 2006-03-01 | バイエル薬品株式会社 | Miniaturized nifedipine nucleated tablets |
EP1575581A1 (en) * | 2002-12-18 | 2005-09-21 | Novartis AG | Combinations of valsartan with cox-2 inhibitors |
-
2006
- 2006-04-18 KR KR1020077026647A patent/KR20080042039A/en not_active Application Discontinuation
- 2006-04-18 CA CA002605183A patent/CA2605183A1/en not_active Abandoned
- 2006-04-18 AU AU2006236497A patent/AU2006236497A1/en not_active Abandoned
- 2006-04-18 WO PCT/US2006/014422 patent/WO2006113631A2/en active Application Filing
- 2006-04-18 JP JP2008507777A patent/JP2008536929A/en active Pending
- 2006-04-18 EP EP06750455A patent/EP1877042A4/en not_active Withdrawn
- 2006-04-18 MX MX2007012947A patent/MX2007012947A/en unknown
-
2007
- 2007-10-17 IL IL186721A patent/IL186721A0/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US20030152622A1 (en) * | 2001-10-25 | 2003-08-14 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral diuretic |
WO2004105694A2 (en) * | 2003-05-22 | 2004-12-09 | Lipocine, Inc. | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
WO2005041929A1 (en) * | 2003-11-03 | 2005-05-12 | Lipocine, Inc | Pharmaceutical compositions with synchronized solubilizer release |
WO2005056607A1 (en) * | 2003-12-12 | 2005-06-23 | Belupo-Lijekovi I Kozmetika D.D. | PROCESS FOR PRODUCTION OF INCLUSION COMPLEXES OF VALSARTAN WITH β-CYCLODEXTRIN |
Non-Patent Citations (1)
Title |
---|
FOGARI, R. ET AL: "Comparative efficacy of losartan and valsartan in mild-to-moderate hypertension: Results of 24-hour ambulatory blood pressure monitoring", CURRENT THERAPEUTIC RESEARCH, vol. 60, no. 4, April 1999 (1999-04-01), pages 195 - 206, XP002575013 * |
Also Published As
Publication number | Publication date |
---|---|
EP1877042A2 (en) | 2008-01-16 |
CA2605183A1 (en) | 2006-10-26 |
IL186721A0 (en) | 2008-02-09 |
WO2006113631A3 (en) | 2006-12-14 |
JP2008536929A (en) | 2008-09-11 |
KR20080042039A (en) | 2008-05-14 |
WO2006113631A2 (en) | 2006-10-26 |
AU2006236497A1 (en) | 2006-10-26 |
MX2007012947A (en) | 2008-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2008004547A0 (en) | Petsticidal compositions | |
GB0503337D0 (en) | Compositions | |
IL186721A0 (en) | Bioenhanced compositions | |
EP1930012A4 (en) | Cellooligosaccharide-containing composition | |
GB0526283D0 (en) | Compositions | |
IL186093A0 (en) | Lignan-containing compositions | |
ZA200705428B (en) | Stable prostaglandin-containing compositions | |
GB0501365D0 (en) | Compositions | |
EP1865042A4 (en) | Frost-preventive composition | |
GB0524128D0 (en) | Compositions | |
GB0508250D0 (en) | Composition | |
GB0506044D0 (en) | Composition | |
EP1847249A4 (en) | Hairdye composition | |
GB0502479D0 (en) | Novel compositions | |
GB0507167D0 (en) | Composition | |
GB0502475D0 (en) | Novel compositions | |
ZA200709913B (en) | Bioenhanced compositions | |
EP1947129A4 (en) | Photoradial- and photocation-curable composition | |
EP1864573A4 (en) | Agricultural-chemical composition | |
GB0525321D0 (en) | Novel compositions | |
GB0526282D0 (en) | Compositions | |
GB0502341D0 (en) | Composition | |
GB0524803D0 (en) | Novel compositions | |
GB0513641D0 (en) | Anti-egeing composition | |
GB0501364D0 (en) | Compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20071116 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1117389 Country of ref document: HK |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 9/50 20060101ALI20110120BHEP Ipc: A61K 9/20 20060101AFI20061113BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20110128 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20110826 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1117389 Country of ref document: HK |